期刊文献+

黑棘皮病与青少年肥胖 被引量:1

Acanthosis nigerians and adolescent obesity
原文传递
导出
摘要 黑棘皮病是青少年肥胖患者中常见的皮肤病变,是青少年肥胖患者体内严重胰岛素抵抗的皮肤标志。在肥胖患者中,高胰岛素血症、炎性反应因子、异常分泌的脂肪细胞因子可促进皮肤组织内的成纤维细胞及角蛋白细胞的增殖,从而促进黑棘皮病的发生。另外,基因多态性同样在这一过程中发挥重要作用。然而青少年肥胖患者黑棘皮病的治疗尚无特效方法,通过饮食、运动及药物改善内胰岛素敏感性可能有效。 Acanthosis nigricans is a common cutaneous disorder in adolescent patients with obesity, which is a cutaneous marker of severe insulin resistance in this population. In obese patients, hyperinsuline- mia, inflammatory factors and abnormal secretion of adipocytokines can promote cellular proliferation of fibro- blasts and keratinocytes in the cutaneous tissue,thereby facilitate the development of aeanthosis nigricans. In addition, gene polymorphism also plays an importan~ role in this process. However,there is no effective thera- py of acanthosis nigricans in adolescent patients with obesity. Improvement of the insulin sensitivity through diet,sport and medication may have benefit effects on acanthosis nigricans.
作者 张志佳 曲伸
出处 《国际内分泌代谢杂志》 北大核心 2013年第3期183-185,共3页 International Journal of Endocrinology and Metabolism
基金 国家自然科学基金资助项目(30971126/C140206) 上海市浦江人才资助项目(PJl408400) 上海市教委科研重点项目(11ZZ33)
关键词 黑棘皮病 青少年肥胖 胰岛素抵抗 脂肪细胞因子 Acanthosis nigricans Adolescent obesity Insulin resistance Adipocytokine
  • 相关文献

参考文献20

  • 1Dassanayake AS, Kasturiratne A, Niriella MA, et al. Prevalence of acanthosis nigricans in an urban population in Sri Lanka and its utility to detect metabolic syndrome. BMC Res Notes, 2011, 4:25.
  • 2Baker JL, Olsen LW, Sobrensen TI, et al. Childhood body-mass in- dex and the risk of coronary heart disease in adulthood. N Engl J Med ,2007,357:2329-2337.
  • 3Brickman WJ, Binns HJ, Jovanovic BD, et al. Acanthosis nigri- eans:a common finding in overweight youth. Pediatr De rmatol, 2007,24:601-606.
  • 4Otto DE, Wang X,Tijierina SL, et al. A comparison of blood pres- sure, body mass index, and acanthosis nigricans in school-age children. J Sch Nuts ,2010,26:223-229.
  • 5Scott AT, Metzig AM, Hames RK, et al. Acanthosis nigricans and oral glucose tolerance in obese children. Clin Pediatr (Phila), 2010,49:69-71.
  • 6Kong AS, Vanderbloemen L, Skipper B, et al. Acanthosis nigTicans predicts the clustering of metabolic syndrome components in His-panic elementary school-aged children. J Pediatr Endocrinol Metab,2012,25 : 1095-1102.
  • 7Felszeghy E, K6poszta R, Juhosz E. Alterations of carbohydrate and lipoprotein metabolism in childhood obesity-impact of insulin resistance and acanthosis nigricans. J Pediatr Endocrinol Metab, 2009,22 : 1117-1126.
  • 8Buzasi K, Sapi Z and Jermendy G. Acanthosis nigricans as a local cutaneous side effect of repeated human insulin injections. Diabetes Res and Clin Pract,2011,94 : e34-e36.
  • 9Higgins SP, Freemark M, Prose NS. Acanthosis nigricans : a practi- cal approach to evaluation and management. Dermatol Online J, 2008,14:2.
  • 10Dubnov-Raz G, Weiss R, Raz R, et al. Acanthosis nigricans and truncal fat in overweight and obese children. J Pediatr Endocrinol Metab, 2011,24 : 697 -701.

二级参考文献23

  • 1傅君芬,梁黎,董关萍,王秀敏,郑敏.假性黑棘皮病肥胖儿童:2型糖尿病的高危人群[J].中华皮肤科杂志,2005,38(7):429-431. 被引量:5
  • 2马军.儿童代谢综合征[J].中国学校卫生,2006,27(10):829-831. 被引量:6
  • 3Jones KL, Arslanian S, Peterokova VA, et al. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care,2002,25:89-94.
  • 4Ten S, Maclaren N. Insulin resistance syndrome in children. Clin Endocrinol Metab ,2004,89:2526-2539.
  • 5Burke JP,Hazuda HP,Hale DE,et al. A quantitative scale of acanthosis nigricans. Diabetes Care, 1999,22 : 1655-1659.
  • 6Gilkison C, Stuart CA. Assessement of patients with acanthosis nigricans skin lesion for hyperinsulinia, insulin resistance and diabetes. Nurse Pract, 1992,17 : 26-32.
  • 7Kay JP, Alemzadeh R, Langley G, et al. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism, 2001,50 : 1457-1461.
  • 8Shubha S, Geoffrey RA, Louise AB, et al. Randomized, controlled trail of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin. Clin Endocrinol Metab,2006,91:2074-2080.
  • 9Scheen AJ, Letiexhe MR, Lefebvre PJ. Short administ ration of metformin improves insulin sensitivity and android obese subjects with impaired glucose tolerance. Diabetic Medicine, 1995,12:985-989.
  • 10Landin K, Tengbom L, Smith U. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. Intern Med, 1991,229 : 181-187.

共引文献2

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部